Cobas

The Cobas® e 801 and Cobas c 503 analyzers are advanced diagnostic instruments developed by Roche Diagnostics for use in clinical laboratories.

Cobas® e 801

It is a fully automated, immunoassay analyzer designed for high-throughput testing of a broad range of analytes in clinical samples. The system supports a comprehensive test menu, including immunoassays for:

• hormones
• tumor markers
• infectious diseases
• cardiac markers
• and more

It allows laboratories to perform a wide range of tests on a single platform. It utilizes advanced electrochemiluminescence (ECL) technology for precise and sensitive detection of analytes. This technology provides high analytical performance, with excellent sensitivity and specificity. The analyzer includes built-in quality control mechanisms to ensure the accuracy, precision, and reliability of test results. It also complies with relevant regulatory standards and guidelines.

Cobas c 503

It is a fully auomated, clinical chemistry analyzer designed for mid- to high-volume testing of biochemical analytes in clinical samples. The cobas c 503 utilizes a combination of photometric and ion-selective electrode (ISE) methods for accurate measurement of analytes.

The analyzer offers with high precision and accuracy a broad menu of clinical chemistry tests, including:

• routine chemistries
• electrolytes
• enzymes
• substrates
• therapeutic drug monitoring assays

It employs innovative technologies for sample and reagent management, ensuring optimal performance and reliability.

Click here to find out which biomarkers are available for testing on these platforms.